(1R,2S,3R)-1-[2-(1,2-Oxazol-3-yl)-1H-imidazol-4-yl]-1,2,3,4-butanetetrol(CAS: 1055027-48-9)

The compound (1R,2S,3R)-1-[2-(1,2-Oxazol-3-yl)-1H-imidazol-4-yl]-1,2,3,4-butanetetrol (CAS: 1055027-48-9) is subject to regulatory guidelines such as GHS classification for hazardous chemicals, REACH regulations in the European Union, and FDA/EPA requirements for use in pharmaceuticals and environmental safety. Specific requirements include documentation of hazard communication, safety data sheets (SDS), and proper labeling.

Alternatives to (1R,2S,3R)-1-[2-(1,2-Oxazol-3-yl)-1H-imidazol-4-yl]-1,2,3,4-butanetetrol (CAS: 1055027-48-9) in synthesis include other similar butanetetrol derivatives with different substituents. Common alternatives may involve the use of isomers or analogs with varying functional groups, which can be synthesized using different reagents and conditions.

The market trend for (1R,2S,3R)-1-[2-(1,2-Oxazol-3-yl)-1H-imidazol-4-yl]-1,2,3,4-butanetetrol (CAS: 1055027-48-9) is focused on its potential applications in pharmaceuticals and biotechnology. Research is driving demand for novel compounds with specific biological activities, leading to a growing interest in its synthesis and characterization. Price trends are influenced by the increasing demand in emerging markets and the development of new therapeutic areas.

Waste containing (1R,2S,3R)-1-[2-(1,2-Oxazol-3-yl)-1H-imidazol-4-yl]-1,2,3,4-butanetetrol (CAS: 1055027-48-9) should be collected in appropriate containers and labeled with the correct hazard information. Proper disposal methods include incineration or professional waste disposal services. Environmental protection precautions such as ensuring no soil or water contamination should be taken, and all disposal procedures must comply with local regulations and guidelines.